Probiotics, gut microbiota, and their influence on host health and disease

Molecular Nutrition and Food Research

Volumn 61, Issue 1, 2017, Pages

  Sánchez, Borja ^a   Delgado, Susana ^a   Blanco Míguez, Aitor ^b   Lourenço, Anália ^b,c   Gueimonde, Miguel ^a   Margolles, Abelardo ^a  

^a DEPARTMENT OF MICROBIOLOGY AND BIOCHEMISTRY OF DAIRY PRODUCTS   (Spain)

^b UNIVERSITY OF VIGO   (Spain)

^c UNIVERSITY OF MINHO   (Portugal)

Author keywords

Gut microbiota; Health effects; Molecular mechanisms bioinformatics; Probiotics

Indexed keywords

PROBIOTIC AGENT;

DIET THERAPY; DRUG EFFECTS; ENTEROPATHY; EVOLUTION; HUMAN; INFLAMMATORY BOWEL DISEASE; INTESTINE FLORA; INTESTINE MUCOSA; MICROBIOLOGY;

BIOLOGICAL EVOLUTION; GASTROINTESTINAL MICROBIOME; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINAL MUCOSA; PROBIOTICS;

EID: 84990931801     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201600240     Document Type: Review

References (137)

1. Hooper, L. V., Gordon, J. I., Commensal host-bacterial relationships in the gut. Science 2001, 292, 1115–1118.
2. Sommer, F., Bäckhed, F., The gut microbiota — masters of host development and physiology. Nat. Rev. Microbiol. 2013, 11, 227–238.
3. Al-Asmakh, M., Zadjali, F., Use of germ-free animal models in microbiota-related research. J. Microbiol. Biotechnol. 2015, 25, 1583–1588.
4. Deplancke, B., Gaskins, H. R., Microbial modulation of innate defense: goblet cells and the intestinal mucus layer. Am. J. Clin. Nutr. 2001, 73, 1131S–1141S.
5. Macpherson, A. J., Harris, N. L., Interactions between commensal intestinal bacteria and the immune system. Nat. Rev. Immunol. 2004, 4, 478–485.
6. Huttenhower, C., Gevers, D., Knight, R., Abubucker, S. et al., Structure, function and diversity of the healthy human microbiome. Nature 2012, 486, 207–214.
7. Methé, B. A., Nelson, K. E., Pop, M., Creasy, H. H. et al., A framework for human microbiome research. Nature 2012, 486, 215–221.
8. Ding, T., Schloss, P. D., Dynamics and associations of microbial community types across the human body. Nature 2014, 509, 357–360.
9. Qin, J., Li, R., Raes, J., Arumugam, M. et al., A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464, 59–65.
10. Costello, E. E. K., Lauber, C. C. L., Hamady, M., Fierer, N. et al., Bacterial community variation in human body habitats across space and time. Science (80-) 2009, 326, 1694–1697.
11. Sender, R., Fuchs, S., Milo, R., Are we really vastly outnumbered? Revisiting the ratio of bacterial to host cells in humans. Cell 2016, 164, 337–340.
12. Ley, R. E., Peterson, D. A., Gordon, J. I., Ecological and evolutionary forces shaping microbial diversity in the human intestine. Cell 2006, 124, 837–848.
13. Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E. et al., Diversity of the human intestinal microbial flora. Science 2005, 308, 1635–1638.
14. Tannock, G. W., What immunologists should know about bacterial communities of the human bowel. Semin. Immunol. 2007, 19, 94–105.
15. Van den Abbeele, P., Belzer, C., Goossens, M., Kleerebezem, M. et al., Butyrate-producing Clostridium cluster XIVa species specifically colonize mucins in an in vitro gut model. ISME J. 2013, 7, 949–961.
16. Arumugam, M., Raes, J., Pelletier, E., Le Paslier, D. et al., Enterotypes of the human gut microbiome. Nature 2011, 12, 174–180.
17. Jeffery, I. B., Claesson, M. J., O'Toole, P. W., Shanahan, F., Categorization of the gut microbiota: enterotypes or gradients? Nat. Rev. Microbiol. 2012, 10, 591–592.
18. Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K. et al., Linking long-term dietary patterns with gut microbial enterotypes. Science 2011, 334, 105–108.
19. Huse, S. M., Ye, Y., Zhou, Y., Fodor, A. A., A core human microbiome as viewed through 16S rRNA sequence clusters. PLoS One 2012, 7, e34242.
20. Wu, G. D., Chen, J., Hoffmann, C., Bittinger, K. et al., NIH Public Access. Science (80-) 2012, 334, 105–108.
21. Knights, D., Ward, T. L., McKinlay, C. E., Miller, H. et al., Rethinking enterotypes. Cell Host Microbe 2014, 16, 433–437.
22. Schrezenmeir, J., de Vrese, M., Probiotics, prebiotics, and synbiotics–approaching a definition. Am. J. Clin. Nutr. 2001, 73, 361S–364S.
23. Gordon, S., Elie Metchnikoff: father of natural immunity. Eur. J. Immunol. 2008, 38, 3257–3264.
24. Lilly, D. M., Stillwell, R. H., Probiotics: growth-promoting factors produced by microorganisms. Science (80-). 1965, 147, 747–748.
25. Parker, R. B., Probiotics, the other half of the antibiotic history. Anim. Nutr. Health 1974, 29, 4–8.
26. Fuller, R., Probiotics in man and animals. J. Appl. Bacteriol. 1989, 66, 365–378.
27. Havenaar, R., Huis In't Veld, J. H. J., Probiotics: a general view. Lact. Acid Bact. 1992, 1, 151–170.
28. Salminen, S., Uniqueness of probiotic strains. IDF Nutr. News Lett. 1995, 5, 16–18.
29. Schaafsma, G., State of art concerning probiotic strains in milk products. IDF Nutr. News Lett. 1996, 5, 23–24.
30. Salminen, S., Bouley, C., Boutron-Ruault, M. C., Cummings, J. H. et al., Functional food science and gastrointestinal physiology and function. Br. J. Nutr. 1998, 80 (Suppl 1), S147–S171.
31. ILSI, Scientific concepts of functional foods in Europe. Consensus document. Br. J. Nutr. 1999, 81 (Suppl 1), S1–S27.
32. Salminen, S., Ouwehand, A., Benno, Y., Lee, Y. K., Probiotics: how should they be defined? Trends Food Sci. Technol. 1999, 10, 107–110.
33. Ouwehand, A. C., Salminen, S. J., The health effects of cultured milk products with viable and non-viable bacteria. Int. Dairy J. 1998, 8, 749–758.
34. Jijon, H., Backer, J., Diaz, H., Yeung, H. et al., DNA from probiotic bacteria modulates murine and human epithelial and immune function. Gastroenterology 2004, 126, 1358–1373.
35. FAO, Probiotics in food. Food Nutr. Pap. 2001, 85, 71.
36. Hill, C., Guarner, F., Reid, G., Gibson, G. R. et al., Expert consensus document: The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nat. Rev. Gastroenterol. Hepatol. 2014, 11, 506–514.
37. Ritchie, M. L., Romanuk, T. N., A meta-analysis of probiotic efficacy for gastrointestinal diseases. PLoS One 2012, 7.
38. Allen, S. J., Martinez, E. G., Gregorio, G. V., Dans, L. F. et al., Probiotics for treating acute infectious diarrhoea. Cochrane Database Syst. Rev. 2010, 11, CD003048.
39. McFarland, L. V., Meta-analysis of probiotics for the prevention of traveler's diarrhea. Travel Med. Infect. Dis. 2007, 5, 97–105.
40. Szajewska, H., Guarino, A., Hojsak, I., Indrio, F. et al., Use of probiotics for management of acute gastroenteritis: a position paper by the ESPGHAN Working Group for Probiotics and Prebiotics. J. Pediatr. Gastroenterol. Nutr. 2014, 58, 531–539.
41. Fiocchi, A., Pawankar, R., Cuello-Garcia, C., Ahn, K. et al., World Allergy Organization-McMaster University Guidelines for Allergic Disease Prevention (GLAD-P): probiotics. World Allergy Organ. J. 2015, 8, 4.
42. Szajewska, H., Kołodziej, M., Systematic review with meta-analysis: Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea. Aliment. Pharmacol. Ther. 2015, 42, 793–801.
43. Szajewska, H., Kołodziej, M., Systematic review with meta-analysis: Lactobacillus rhamnosus GG in the prevention of antibiotic-associated diarrhoea in children and adults. Aliment. Pharmacol. Ther. 2015, 42, 1149–1157.
44. Szajewska, H., Canani, R. B., Guarino, A., Hojsak, I. et al., Probiotics for the prevention of antibiotic-associated diarrhea in children. J. Pediatr. Gastroenterol. Nutr. 2016, 62, 495–506.
45. Hevia, A., Delgado, S., Margolles, A., Sánchez, B., Application of density gradient for the isolation of the fecal microbial stool component and the potential use thereof. Sci. Rep. 2015, 5, 16807.
46. Elahi, B., Nikfar, S., Derakhshani, S., Vafaie, M. et al., On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. Dig. Dis. Sci. 2008, 53, 1278–1284.
47. Marteau, P., Sokol, H., Dray, X., Seksik, P., Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors? Gastroentérol. Clin. Biol. 2009, 33 (Suppl 3), S228–S234.
48. Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F. et al., The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review. Gut 2010, 59, 325–332.
49. Spiller, R., Review article: probiotics and prebiotics in irritable bowel syndrome. Aliment. Pharmacol. Ther. 2008, 28, 385–396.
50. Lesbros-Pantoflickova, D., Corthésy-Theulaz, I., Blum, A. L., Helicobacter pylori and probiotics. J. Nutr. 2007, 137, 812S–818S.
51. Homan, M., Orel, R., Are probiotics useful in Helicobacter pylori eradication? World J. Gastroenterol. 2015, 21, 10644–10653.
52. de Vrese, M., Stegelmann, A., Richter, B., Fenselau, S. et al., Probiotics–compensation for lactase insufficiency. Am. J. Clin. Nutr. 2001, 73, 421S–429S.
53. Sánchez, B., De Los Reyes-Gavilan, C. G., Margolles, A., Gueimonde, M., Probiotic fermented milks: present and future. Int. J. Dairy Technol. 2009, 62, 472–483.
54. Tojo, R., Suárez, A., Clemente, M. G., De Los Reyes-Gavilán, C. G. et al., Intestinal microbiota in health and disease: Role of bifidobacteria in gut homeostasis. World J. Gastroenterol. 2014, 20, 15163–15176.
55. Maynard, C. L., Elson, C. O., Hatton, R. D., Weaver, C. T., Reciprocal interactions of the intestinal microbiota and immune system. Nature 2012, 489, 231–241.
56. Johansson, M. E. V., Larsson, J. M. H., Hansson, G. C., The two mucus layers of colon are organized by the MUC2 mucin, whereas the outer layer is a legislator of host-microbial interactions. Proc. Natl. Acad. Sci. U S A 2011, 108 (Suppl), 4659–4665.
57. Goto, Y., Ivanov, I. I., Intestinal epithelial cells as mediators of the commensal-host immune crosstalk. Immunol. Cell Biol. 2013, 91, 204–214.
58. Kamada, N., Seo, S.-U., Chen, G. Y., Núñez, G., Role of the gut microbiota in immunity and inflammatory disease. Nat. Rev. Immunol. 2013, 13, 321–335.
59. Bouskra, D., Brézillon, C., Bérard, M., Werts, C. et al., Lymphoid tissue genesis induced by commensals through NOD1 regulates intestinal homeostasis. Nature 2008, 456, 507–510.
60. Wang, Y., Begum-Haque, S., Telesford, K. M., Ochoa-Repáraz, J. et al., A commensal bacterial product elicits and modulates migratory capacity of CD39(+) CD4 T regulatory subsets in the suppression of neuroinflammation. Gut Microbes 2014, 5, 552–561.
61. Bernardo, D., Sánchez, B., Al-Hassi, H. O., Mann, E. R. et al., Microbiota/host crosstalk biomarkers: regulatory response of human intestinal dendritic cells exposed to Lactobacillus extracellular encrypted peptide. PLoS One 2012, 7, 1–8.
62. Al-Hassi, H. O., Mann, E. R., Sanchez, B., English, N. R. et al., Altered human gut dendritic cell properties in ulcerative colitis are reversed by Lactobacillus plantarum extracellular encrypted peptide STp. Mol. Nutr. Food Res. 2014, 58, 1132–1143.
63. Atarashi, K., Tanoue, T., Oshima, K., Suda, W. et al., Treg induction by a rationally selected mixture of Clostridia strains from the human microbiota. Nature 2013, 500, 232–236.
64. Louis, P., Hold, G. L., Flint, H. J., The gut microbiota, bacterial metabolites and colorectal cancer. Nat. Rev. Microbiol. 2014, 12, 661–672.
65. Quévrain, E., Maubert, M. A., Michon, C., Chain, F. et al., Identification of an anti-inflammatory protein from Faecalibacterium prausnitzii, a commensal bacterium deficient in Crohn's disease. Gut 2015, 65, 415–425.
66. Ruiz, L., Hevia, A., Bernardo, D., Margolles, A. et al., Extracellular molecular effectors mediating probiotic attributes. FEMS Microbiol. Lett. 2014, 359, 1–11.
67. Arthur, J. C., Gharaibeh, R. Z., Urines, J. M., Perez-Chanona, E. et al., VSL#3 probiotic modifies mucosal microbial composition but does not reduce colitis-associated colorectal cancer. Sci. Rep. 2013, 3, 2868.
68. Sugahara, H., Odamaki, T., Fukuda, S., Kato, T. et al., Probiotic Bifidobacterium longum alters gut luminal metabolism through modification of the gut microbial community. Nature 2015, 5, 1–11.
69. Turroni, F., Milani, C., Duranti, S., Mancabelli, L. et al., Deciphering bifidobacterial-mediated metabolic interactions and their impact on gut microbiota by a multi-omics approach. ISME J. 2016, 10, 1656–1668.
70. Wang, W.-L., Xu, S.-Y., Ren, Z.-G., Tao, L. et al., Application of metagenomics in the human gut microbiome. World J. Gastroenterol. 2015, 21, 803–814.
71. McNulty, N. P., Yatsunenko, T., Hsiao, A., Faith, J. J. et al., The impact of a consortium of fermented milk strains on the gut microbiome of gnotobiotic mice and monozygotic twins. Sci. Transl. Med. 2011, 3, 106ra106.
72. Lahtinen, S. J., Forssten, S., Aakko, J., Granlund, L. et al., Probiotic cheese containing Lactobacillus rhamnosus HN001 and Lactobacillus acidophilus NCFMۚ modifies subpopulations of fecal lactobacilli and Clostridium difficile in the elderly. Age 2012, 34, 133–143.
73. Nadja, L., Vogensen, F. K., Gøbe, R., Michaelsen, K. F. et al., Predominant genera of fecal microbiota in children with atopic dermatitis are not altered by intake of probiotic bacteria Lactobacillus acidophilusNCFM andBi¢dobacterium animalis subsp.lactisBi-07. FEMS Microbiol. Ecol. 2011, 75, 482–496.
74. Plaza-Díaz, J., Fernández-Caballero, J. Á., Chueca, N., García, F. et al., Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains. Nutrients 2015, 7, 3999–4015.
75. Larsen, N., Vogensen, F. K., Gøbel, R. J., Michaelsen, K. F. et al., Effect of Lactobacillus salivarius Ls-33 on fecal microbiota in obese adolescents. Clin. Nutr. 2013, 32, 935–940.
76. Lyra, A., Krogius-Kurikka, L., Nikkilä, J., Malinen, E. et al., Effect of a multispecies probiotic supplement on quantity of irritable bowel syndrome-related intestinal microbial phylotypes. BMC Gastroenterol. 2010, 10, 110.
77. Veiga, P., Pons, N., Agrawal, A., Oozeer, R. et al., Changes of the human gut microbiome induced by a fermented milk product. Sci. Rep. 2014, 4, 1–9.
78. Hong, Y.-S., Hong, K. S., Park, M.-H., Ahn, Y.-T. et al., Metabonomic understanding of probiotic effects in humans with irritable bowel syndrome. J. Clin. Gastroenterol. 2011, 45, 415–425.
79. Patel, R., Dupont, H. L., New approaches for bacteriotherapy: prebiotics, new-generation probiotics, and synbiotics. Clin. Infect. Dis. 2015, 60, S108–S121.
80. van Zanten, G. C., Krych, L., Röytiö, H., Forssten, S. et al., Synbiotic Lactobacillus acidophilus NCFM and cellobiose does not affect human gut bacterial diversity but increases abundance of lactobacilli, bifidobacteria and branched-chain fatty acids: a randomized, double-blinded cross-over trial. FEMS Microbiol. Ecol. 2014, 90, 225–236.
81. Derrien, M., van Hylckama Vlieg, J. E., Fate, activity, and impact of ingested bacteria within the human gut microbiota. Trends Microbiol. 2015, 23, 354–366.
82. Sánchez, B., Noriega, L., Ruas-Madiedo, P., de los Reyes-Gavilán, C. G. et al., Acquired resistance to bile increases fructose-6-phosphate phosphoketolase activity in Bifidobacterium. FEMS Microbiol. Lett. 2004, 235, 35–41.
83. Turroni, F., Özcan, E., Milani, C., Mancabelli, L. et al., Glycan cross-feeding activities between bifidobacteria under in vitro conditions. Front. Microbiol. 2015, 6, 1030.
84. Egan, M., Motherway, M. O., Kilcoyne, M., Kane, M. et al., Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium. BMC Microbiol. 2014, 14, 282.
85. Egan, M., Motherway, M. O. C., Ventura, M., van Sinderen, D., Metabolism of sialic acid by Bifidobacterium breve UCC2003. Appl. Environ. Microbiol. 2014, 80, 4414–4426.
86. Rios-Covian, D., Gueimonde, M., Duncan, S. H., Flint, H. J. et al., Enhanced butyrate formation by cross-feeding between Faecalibacterium prausnitzii and Bifidobacterium adolescentis. FEMS Microbiol. Lett. 2015, 362, fnv176.
87. Cadwell, K., Expanding the role of the virome: commensalism in the gut. J. Virol. 2015, 89, 1951–1953.
88. Duerkop, B. A., Hooper, L. V., Resident viruses and their interactions with the immune system. Nat. Immunol. 2013, 14, 654–659.
89. Berni Canani, R., Sangwan, N., Stefka, A. T., Nocerino, R. et al., Lactobacillus rhamnosus GG-supplemented formula expands butyrate-producing bacterial strains in food allergic infants. ISME J. 2015, 10, 1–9.
90. Ferrario, C., Taverniti, V., Milani, C., Fiore, W. et al., Modulation of fecal Clostridiales bacteria and butyrate by probiotic intervention with Lactobacillus paracasei DG varies among healthy adults. J. Nutr. 2014, 144, 1787–1796.
91. Caporaso, J. G., Lauber, C. L., Costello, E. K., Berg-Lyons, D. et al., Moving pictures of the human microbiome. Genome Biol. 2011, 12, R50.
92. Andreas, N. J., Kampmann, B., Le-Doare, M. K., Human breast milk: a review on its composition and bioactivity. Early Hum. Dev. 2015, 91, 629–635.
93. Arboleya, S., Ruas-Madiedo, P., Margolles, A., Solís, G. et al., Characterization and in vitro properties of potentially probiotic Bifidobacterium strains isolated from breast-milk. Int. J. Food Microbiol. 2011, 149, 28–36.
94. Turroni, F., Peano, C., Pass, D. A., Foroni, E. et al., Diversity of bifidobacteria within the infant gut microbiota. PLoS One 2012, 7, e36957.
95. Qin, J., Li, Y., Cai, Z., Li, S. et al., A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 2012, 490, 55–60.
96. Joossens, M., Huys, G., Cnockaert, M., Preter, V. D. et al., Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011, 60, 631–637.
97. Hevia, A., Milani, C., López, P., Cuervo, A. et al., Intestinal dysbiosis associated with systemic lupus erythematosus. MBio 2014, 5, e01548–e01514.
98. Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y. et al., The treatment-naive microbiome in new-onset Crohn's Disease. Cell Host Microbe 2014, 15, 382–392.
99. Machiels, K., Sabino, J., Vandermosten, L., Joossens, M. et al., Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. Gut 2015, doi: 10.1136/gutjnl-2015-309398.
100. Morgan, X. C., Tickle, T. L., Sokol, H., Gevers, D. et al., Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012, 13, R79.
101. Milani, C., Hevia, A., Foroni, E., Duranti, S. et al., Assessing the fecal microbiota: an optimized ion torrent 16S rRNA gene-based analysis protocol. PLoS One 2013, 8, e68739.
102. Miquel, S., Martín, R., Rossi, O., Bermúdez-Humarán, L. G. et al., Faecalibacterium prausnitzii and human intestinal health. Curr. Opin. Microbiol. 2013, 16, 255–261.
103. Petrof, E. O., Khoruts, A., From stool transplants to next-generation microbiota therapeutics. Gastroenterology 2014, 146, 1573–1582.
104. Riehle, K., Coarfa, C., Jackson, A., Ma, J. et al., The Genboree Microbiome Toolset and the analysis of 16S rRNA microbial sequences. BMC Bioinformatics 2012, 13 (Suppl 1), S11.
105. Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K. et al., QIIME allows analysis of high-throughput community sequencing data. Nat. Methods 2010, 7, 335–336.
106. Schloss, P. D., Westcott, S. L., Ryabin, T., Hall, J. R. et al., Introducing mothur: open-source, platform-independent, community-supported software for describing and comparing microbial communities. Appl. Environ. Microbiol. 2009, 75, 7537–7541.
107. Huson, D. H., Xie, C., A poor man's BLASTX–high-throughput metagenomic protein database search using PAUDA. Bioinformatics 2014, 30, 38–39.
108. Li, W., Godzik, A., Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 2006, 22, 1658–1659.
109. Haas, B. J., Gevers, D., Earl, A. M., Feldgarden, M. et al., Chimeric 16S rRNA sequence formation and detection in Sanger and 454-pyrosequenced PCR amplicons. Genome Res. 2011, 21, 494–504.
110. Wang, Q., Garrity, G. M., Tiedje, J. M., Cole, J. R., Naive Bayesian classifier for rapid assignment of rRNA sequences into the new bacterial taxonomy. Appl. Environ. Microbiol. 2007, 73, 5261–5267.
111. Langmead, B., Salzberg, S. L., Fast gapped-read alignment with Bowtie 2. Nat. Methods 2012, 9, 357–359.
112. Kanehisa, M., Goto, S., Sato, Y., Furumichi, M. et al., KEGG for integration and interpretation of large-scale molecular data sets. Nucleic Acids Res. 2012, 40, D109–D114.
113. Abubucker, S., Segata, N., Goll, J., Schubert, A. M. et al., Metabolic reconstruction for metagenomic data and its application to the human microbiome. PLoS Comput. Biol. 2012, 8, e1002358.
114. Segata, N., Izard, J., Waldron, L., Gevers, D. et al., Metagenomic biomarker discovery and explanation. Genome Biol. 2011, 12, R60.
115. Peng, Y., Leung, H. C. M., Yiu, S. M., Chin, F. Y. L., IDBA-UD: a de novo assembler for single-cell and metagenomic sequencing data with highly uneven depth. Bioinformatics 2012, 28, 1420–1428.
116. Nielsen, H. B., Almeida, M., Juncker, A. S., Rasmussen, S. et al., Identification and assembly of genomes and genetic elements in complex metagenomic samples without using reference genomes. Nat. Biotechnol. 2014, 32, 822–828.
117. Kurtz, S., Phillippy, A., Delcher, A. L., Smoot, M. et al., Versatile and open software for comparing large genomes. Genome Biol. 2004, 5, R12.
118. Xu, Z., Hao, B., CVTree update: a newly designed phylogenetic study platform using composition vectors and whole genomes. Nucleic Acids Res. 2009, 37, W174–W178.
119. Segata, N., Waldron, L., Ballarini, A., Narasimhan, V. et al., Metagenomic microbial community profiling using unique clade-specific marker genes. Nat. Methods 2012, 9, 811–814.
120. Mende, D. R., Sunagawa, S., Zeller, G., Bork, P., Accurate and universal delineation of prokaryotic species. Nat. Methods 2013, 10, 881–884.
121. Zhang, C., Yin, A., Li, H., Wang, R. et al., Dietary Modulation of Gut Microbiota Contributes to Alleviation of Both Genetic and Simple Obesity in Children. EBioMedicine 2015, 2, 966–982.
122. Kanehisa, M., Goto, S., Sato, Y., Kawashima, M. et al., Data, information, knowledge and principle: Back to metabolism in KEGG. Nucleic Acids Res. 2014, 42, D199–D205.
123. Caspi, R., Altman, T., Billington, R., Dreher, K. et al., The MetaCyc database of metabolic pathways and enzymes and the BioCyc collection of Pathway/Genome Databases. Nucleic Acids Res. 2014, 44, D471–D480.
124. Overbeek, R., Olson, R., Pusch, G. D., Olsen, G. J. et al., The SEED and the Rapid Annotation of microbial genomes using Subsystems Technology (RAST). Nucleic Acids Res. 2014, 42, D206–D214.
125. Saier, M. H., Reddy, V. S., Tsu, B. V., Ahmed, M. S. et al., The Transporter Classification Database (TCDB): recent advances. Nucleic Acids Res. 2016, 44, D372–D379.
126. Burgard, A. P., Pharkya, P., Maranas, C. D., Optknock: a bilevel programming framework for identifying gene knockout strategies for microbial strain optimization. Biotechnol. Bioeng. 2003, 84, 647–657.
127. Schellenberger, J., Que, R., Fleming, R. M. T., Thiele, I. et al., Quantitative prediction of cellular metabolism with constraint-based models: the COBRA Toolbox v2.0. Nat. Protoc. 2011, 6, 1290–1307.
128. Greenblum, S., Turnbaugh, P. J., Borenstein, E., Metagenomic systems biology of the human gut microbiome reveals topological shifts associated with obesity and inflammatory bowel disease. Proc. Natl. Acad. Sci. U S A 2012, 109, 594–599.
129. Xu, N., Liu, J., Ai, L., Liu, L., Reconstruction and analysis of the genome-scale metabolic model of Lactobacillus casei LC2W. Gene 2015, 554, 140–147.
130. El-Semman, I. E., Karlsson, F. H., Shoaie, S., Nookaew, I. et al., Genome-scale metabolic reconstructions of Bifidobacterium adolescentis L2-32 and Faecalibacterium prausnitzii A2-165 and their interaction. BMC Syst. Biol. 2014, 8, 41.
131. Ji, B., Nielsen, J., From next-generation sequencing to systematic modeling of the gut microbiome. Front. Genet. 2015, 6, 219.
132. Moriya, Y., Shigemizu, D., Hattori, M., Tokimatsu, T. et al., PathPred: an enzyme-catalyzed metabolic pathway prediction server. Nucleic Acids Res. 2010, 38, W138–W143.
133. Ibrahim, M., Anishetty, S., A meta-metabolome network of carbohydrate metabolism: interactions between gut microbiota and host. Biochem. Biophys. Res. Commun. 2012, 428, 278–284.
134. Steinway, S. N., Biggs, M. B., Loughran, T. P., Papin, J. A. et al., Inference of network dynamics and metabolic interactions in the gut microbiome. PLoS Comput. Biol. 2015, 11, e1004338.
135. Ni, Y., Li, J., Panagiotou, G., A molecular-level landscape of diet-gut microbiome interactions: toward dietary interventions targeting bacterial genes. MBio 2015, 6, e01263–e01215.
136. Saito, R., Smoot, M. E., Ono, K., Ruscheinski, J., A travel guide to Cytoscape plugins. Nat. Methods 2012, 9, 1069–1076.
137. Kristensen, N. B., Bryrup, T., Allin, K. H., Nielsen, T. et al., Alterations in fecal microbiota composition by probiotic supplementation in healthy adults: a systematic review of randomized controlled trials. Genome Med. 2016, 8, 52.